Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Bristol-Myers Squibb Company is ...

Discover Kymera Therapeutics' Q3 2025 earnings, clinical trial milestones in immunology, and strategic Gilead partnership.

New research reveals that men need twice as much exercise as women to prevent heart disease. The study shows that women ...

ConvaTec Group plc ((GB:CTEC)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Bitcoin price enters euphoria phase – on-chain frameworks like cycle master forecast $180k peak, signaling bull cycle top with $260k overvalued zone in sight. The bitcoin price has now entered the ...

Legence (NASDAQ:LGN), a recently listed engineering and construction services provider, is drawing wide attention from Wall Street analysts, with new coverage highlighting the company’s leverage to ...

A new study details howPresident Trump's tariffs could make many things more expensive this holiday season. Here's a look at the Trump tariffs impact.

Identity resolution often anchors vendor pitches. Vendors claim CDPs can merge disparate identifiers into coherent customer ...

Presented at the European Society for Medical Oncology, study results showed Datroway extended survival in breast cancer ...

The Canadian Investment Regulatory Organization’s (CIRO) decision to abandon its retail client-data project is indefensible.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at ...